<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<HTML>
<HEAD>
<TITLE>extropians: telomerase: a new perspective</TITLE>
<META NAME="Author" CONTENT="Don Klemencic (klemencc@sgi.net)">
<META NAME="Subject" CONTENT="telomerase: a new perspective">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<H1>telomerase: a new perspective</H1>
<!-- received="Mon Aug 21 00:15:53 2000" -->
<!-- isoreceived="20000821061553" -->
<!-- sent="Mon, 21 Aug 2000 02:15:16 -0400" -->
<!-- isosent="20000821061516" -->
<!-- name="Don Klemencic" -->
<!-- email="klemencc@sgi.net" -->
<!-- subject="telomerase: a new perspective" -->
<!-- id="000001c00b37$2e0721a0$ed82a6d1@donaldkl" -->
<!-- inreplyto="398572FB.DDE6B356@tiki-lounge.com" -->
<STRONG>From:</STRONG> Don Klemencic (<A HREF="mailto:klemencc@sgi.net?Subject=Re:%20telomerase:%20a%20new%20perspective&In-Reply-To=&lt;000001c00b37$2e0721a0$ed82a6d1@donaldkl&gt;"><EM>klemencc@sgi.net</EM></A>)<BR>
<STRONG>Date:</STRONG> Mon Aug 21 2000 - 00:15:16 MDT
<P>
<!-- next="start" -->
<UL>
<LI><STRONG>Next message:</STRONG> <A HREF="3410.html">Damien Broderick: "Re: telomerase: a new perspective"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="3408.html">phil osborn: "Re: Reward for identity? Re: Limits of tolerance"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="2274.html">Ross A. Finlayson: "Re: writers"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="3410.html">Damien Broderick: "Re: telomerase: a new perspective"</A>
<LI><STRONG>Reply:</STRONG> <A HREF="3410.html">Damien Broderick: "Re: telomerase: a new perspective"</A>
<LI><STRONG>Reply:</STRONG> <A HREF="3415.html">Ross A. Finlayson: "Re: telomerase: a new perspective"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#3409">[ date ]</A>
<A HREF="index.html#3409">[ thread ]</A>
<A HREF="subject.html#3409">[ subject ]</A>
<A HREF="author.html#3409">[ author ]</A>
</UL>
<HR NOSHADE><P>
<!-- body="start" -->
<P>
There is research news from the Dana-Farber Cancer Institute, associated
<BR>
with Harvard University:
<BR>
<A HREF="http://www.dfci.harvard.edu/dfci/news/ie4/telomere.shtml">http://www.dfci.harvard.edu/dfci/news/ie4/telomere.shtml</A>
<BR>
and reported in Science Daily:
<BR>
<A HREF="http://www.sciencedaily.com/releases/2000/08/000811064001.htm">http://www.sciencedaily.com/releases/2000/08/000811064001.htm</A>
<BR>
<P>In aging humans tumors tend to appear in epithelial tissue. Because of a
<BR>
lack of telomerase, when telomeres have been used up, cell division leads to
<BR>
massive chromosomal damage. These cells enter a state called 'crisis'. If
<BR>
they then regain the ability to make telomerase, these genetically damaged
<BR>
cells move toward a cancerous state.
<BR>
<P>Normal mice produce telomerase in the epithelial tissues. Although they get
<BR>
other kinds of cancers, they don't develop cancers like those seen in aging
<BR>
humans. When knockout mice were created that did not produce telomerase in
<BR>
the epithelial tissues, they exhibited cancer development like that seen in
<BR>
aging humans.
<BR>
<P>This strikes me as very good news. It appears that the 'dark side' of
<BR>
telomerase is manifested only when cells regain telomerase after having been
<BR>
previously damaged by its absence. That seems to brighten considerably the
<BR>
prospect of using telomerase as a component in an anti-aging therapy.
<BR>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Don Klemencic
<BR>
<P><!-- body="end" -->
<HR NOSHADE>
<UL>
<!-- next="start" -->
<LI><STRONG>Next message:</STRONG> <A HREF="3410.html">Damien Broderick: "Re: telomerase: a new perspective"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="3408.html">phil osborn: "Re: Reward for identity? Re: Limits of tolerance"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="2274.html">Ross A. Finlayson: "Re: writers"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="3410.html">Damien Broderick: "Re: telomerase: a new perspective"</A>
<LI><STRONG>Reply:</STRONG> <A HREF="3410.html">Damien Broderick: "Re: telomerase: a new perspective"</A>
<LI><STRONG>Reply:</STRONG> <A HREF="3415.html">Ross A. Finlayson: "Re: telomerase: a new perspective"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#3409">[ date ]</A>
<A HREF="index.html#3409">[ thread ]</A>
<A HREF="subject.html#3409">[ subject ]</A>
<A HREF="author.html#3409">[ author ]</A>
</UL>
<!-- trailer="footer" -->
<HR NOSHADE>
<P>
<SMALL>
<EM>
This archive was generated by <A HREF="http://www.hypermail.org/">hypermail 2b29</A> 
: <EM>Mon Oct 02 2000 - 17:36:22 MDT</EM>
</EM>
</SMALL>
</BODY>
</HTML>
